Eagle Pharmaceuticals (EGRX) Tops Q4 EPS by 66c, Sales Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. DOX
5. CRWD
6. CHKP
7. ON
8. HNGE
9. INSP
10. SPY

Go back to Eagle Pharmaceuticals (EGRX) Tops Q4 EPS by 66c, Sales Miss

Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2016 Results

March 1, 2017 6:50 AM EST

-- Bendeka® market share grew to 92% --

-- Bendeka reached $500 million in cumulative sales in Q1 2017, triggering $25 million milestone --

-- 2016 Revenue grew 186% to $189.5 million --

-- Q4 2016 income before tax benefit grew to $28.3 million, including $15.6 million of accelerated and non-recurring expenses

-- Q4 2016 EPS grew to $3.75 per basic and $3.52 per diluted share --

-- Full Year 2016 income before tax benefit grew to $53.4 million --

-- Full Year 2016 EPS grew to $5.24 per... More